ReviewCureus2025
Prevalence and Risk Factors of Subclinical and Overt Hypothyroidism in Saudi Arabia: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The impact of subclinical hypothyroidism on core reproductive hormones and ovarian endocrine status in patients with polycystic ovary syndrome: a systematic review and meta-analysis.Frontiers in endocrinology · 2026Pooled it
- Article
- Post-Levothyroxine Thyroid Dysfunction in Saudi Arabian Patients with Hypothyroidism: A Cross-Sectional Study.Clinics and practice · 2026Article
- Body composition indices align with thyroid variation in euthyroid Saudi adults: A cross-sectional study.The Journal of international medical research · 2026Article
- Understanding the Drivers of Hypothyroidism in Patients Undergoing Chronic Hemodialysis.Diagnostics (Basel, Switzerland) · 2026Article
- Impact of maternal hypothyroidism on human milk macronutrient content and fatty acid composition: a prospective cohort study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypothyroidism, whether subclinical (SCH) or overt (OH), stands among the most common yet often overlooked endocrine disorders, with its prevalence varying widely across different populations. In Saudi Arabia, factors such as metabolic comorbidities, genetic predisposition, and regional disparities contribute to its epidemiology. This systematic review aimed to summarize the existing literature on the prevalence and risk factors of SCH and OH in Saudi Arabia to lead clinical practice and public health strategies. A comprehensive literature search was conducted to identify relevant studies published in the past decade. Studies meeting predefined inclusion criteria were selected, and data on study characteristics, prevalence, risk factors, and diagnostic methods were extracted. Methodological quality was assessed using a standardized appraisal tool. Due to heterogeneity, a narrative synthesis was performed. Reported prevalence rates varied across populations, with higher rates observed in certain groups such as pregnant women and individuals with specific comorbidities. Female gender, advanced age, family history, and chronic conditions were associated risk factors. Broader screening approaches in pregnancy appeared to identify more SCH cases than selective strategies. Regional differences in prevalence within Saudi Arabia were also noted. Most included studies demonstrated low to moderate risk of bias. The burden of hypothyroidism in Saudi Arabia varies by population and region, with distinct risk factors underscoring the need for tailored screening and management. Expanded screening in high-risk groups and further research on causal pathways are recommended to address this growing health concern.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.